Ireland
--:--IST
Recruiting Not applicable

Empathy and (Self-)Compassion in Parkinson's Disease Patients and Caregivers

NCT07097298 · tracked via the Priya Life Science Switzerland tracker
Sponsor
Alain Kaelin
Phase
Not applicable
Started
2025-11-06
Last updated
2025-12-01

Condition(s) studied

Parkinson Disease(PD)

Investigational drug(s) / intervention(s)

empathy and compassion training

empathy and compassion training: A 6-week empathy and compassion training will be designed and delivered involving PD patients and caregivers. During the compassion training participants will do mindfulness, writing and poetry exercises

Study summary

The goal of this clinical trial is to improve quality of life in Parkinson's Disease (PD) patients by increasing their empathy and their (self-)compassion. The main question it aims to answer is:

Does the level of quality of life in PD patients and caregivers improve after empathy/(self-)compassion training?

Participants will be delivered a 6-week empathy and compassion training (mindfulness, writing and poetry exercises addressing the cognitive, emotional, motivational and behavioural components of (self-)compassion) and will also be asked to answer questionnaires before and after the training

Eligibility

Sex
ALL
Min age
50 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosis of PD * Hoehn and Yahr scale, stage ≤ 3 * Mini Mental State Examination with a score ≥ 26 * Able to give informed consent as documented by signature * At least, secondary school education * To have a regular caregiver at home Exclusion Criteria: * Any medical condition that is not PD, such as drug induced parkinsonism * Major depression, dysthymia, or according to DSM-V * Other neurological or psychiatric diseases * Neuropsychological scores compatible with the diagnosis of early dementia * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, etc For CAREGIVERS: Inclusion criteria * Taking care of the patient on a regular basis, i.e., at least 3 days per week * Being caregiver of the patients for at least 3 months * At least, secondary school education * Written informed consent

Primary outcome measure(s)

  • PD patients quality of life improvement — from baseline to the end of intervention (6weeks)
    the change (no min / max values foreseen) in the level of quality of life in PD patients as measured by the Parkinson's Disease Questionnaire (PDQ-8), which assesses 8 domains of quality of life: mobility, activities of daily of living, emotional well-being, stigma, social support, cognition, communication, and bodily discomfort; higher scores indicate a worse quality of life

Trial sites (1)

FacilityCityRegionStatus
Istituto di Neuroscienze Cliniche della Svizzera Italiana, EOC Lugano Switzerland Recruiting

More Alain Kaelin trials in Switzerland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07097298 on ClinicalTrials.gov ↗ ← All trials in Switzerland